Abbott Cooper PLLC has initiated an investigation on behalf of Estrella Immunopharma, Inc. stockholders to determine if the company's board of directors violated fiduciary duties or engaged in wrongdoing. Estrella's stock trades on Nasdaq under the symbol ESLA. Stockholders interested in their legal rights can contact Abbott Cooper PLLC at no cost, as the firm works on a contingency fee basis. This investigation could lead to legal action if breaches are found, impacting shareholder value and corporate governance.
Milestone Pharmaceuticals announced the grant of 33,000 stock options to a newly hired employee as an inducement under Nasdaq Listing Rule 5635(c)(4). The options, priced at $0.72 each, will vest over four years with a one-year cliff and monthly inst...
BitMart, a crypto exchange in the Cayman Islands, suffered a $391,000 hack on November 2, 2026, during its court-supervised restructuring and after halting trading in August. The stolen funds came from wallets on Ethereum layer-2 networks Base, Arbit...
Frax Finance announced that its dollar-linked stablecoin, Frax USD (frxUSD), is backed by 103% collateral. A new reserve tracker, launched in partnership with DefiLlama on November 2, provides real-time visibility into the stablecoin's reserves, cove...
Anatoly Yakovenko, co-founder of Solana Labs, posted a brief message advising data center operators to "pivot to crypto." This suggests a growing overlap between traditional data center services and blockchain-based computing, especially as high-perf...
Midterm election projections indicate Democrats could flip 30 seats in the U.S. House, securing a strong majority. This political forecast coincides with Bitcoin's price falling below $77,000, marking a notable dip in the crypto market. While the ele...
